MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression

Cancer Letters

Volumn 362, Issue 1, 2015, Pages 122-130

  Chen, Shuo ^a   Chen, Xi ^a   Xiu, Yin Ling ^a   Sun, Kai Xuan ^a   Zhao, Yang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

CDK1; Cell proliferation; MiR 490 3P; Ovarian epithelial carcinoma; Tumorigenesis and progression

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 1; GELATINASE A; GELATINASE B; MEMBRANE PROTEIN; MICRORNA; MICRORNA 490 3P; PROTEIN BCL XL; PROTEIN P53; PROTEIN SMARCD1; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; CDK1 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; MESSENGER RNA; MIRN490 MICRORNA, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER STAGING; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; MOLECULAR MECHANICS; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN TARGETING; REGULATORY MECHANISM; 3' UNTRANSLATED REGION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; METABOLISM; MOLECULAR GENETICS; NEOPLASM; NUCLEOTIDE SEQUENCE; NUDE MOUSE; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; CARCINOGENESIS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASES; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HETEROGRAFTS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; RNA, MESSENGER; TRANSFECTION;

EID: 84931080118     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.03.029     Document Type: Article

References (37)

1. Menon U., Gentry-Maharaj A., Jacobs I. Ovarian cancer screening and mortality. JAMA 2011, 306(14):1544.
2. Haruta S., Furukawa N., Yoshizawa Y., Tsunemi T., Nagai A., Kawaguchi R., et al. Molecular genetics and epidemiology of epithelial ovarian cancer. Oncol. Rep 2011, 26(6):1347-1356.
3. Jordan S.J., Cushing-Haugen K.L., Wicklund K.G., Doherty J.A., Rossing M.A. Breast-feeding and risk of epithelial ovarian cancer. Cancer Causes Control 2012, 23(6):919-927.
4. Ji K., Ye L., Mason M.D., Jiang W.G. The Kiss-1/Kiss-1R complex as a negative regulator of cell motility and cancer metastasis (Review). Int. J. Mol. Med 2013, 32(4):747-754.
5. Lee R.C., Feinbaum R.L., Ambros V. The C.elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
6. Pasquinelli A.E. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat. Rev. Genet 2012, 13:271-282.
7. Shen J., Xiao Z., Wu W.K., Wang M.H., To K.F., Chen Y., et al. Epigenetic silencing of miR-490-3p reactivates the chromatin remodeler sMARCD1 to promote Helicobacter pylori-induced gastric carcinogenesis. Cancer Res 2015, 75(4):754-765.
8. Gu H., Yang T., Fu S., Chen X., Guo L., Ni Y. MicroRNA-490-3p inhibits proliferation of A549 lung cancer cells by targeting CCND1. Biochem. Biophys. Res. Commun 2014, 444:104-108.
9. Nigg E.A. Mitotic kinases as regulators of cell division and its checkpoints. Nat. Rev. Mol. Cell Biol 2001, 2:21-32.
10. Lee J.Y., Jeong W., Kim J.H., Kim J., Bazer F.W., Han J.Y., et al. Distinct expression pattern and post-transcriptional regulation of cell cycle genes in the glandular epithelia of avian ovarian carcinomas. PLoS ONE 2012, 7(12). e51592.
11. Song E.Y., Qu C.F., Rizvi S.M., Raja C., Beretov J., Morgenstern A., et al. Bismuth-213 radioimmunotherapy with C595 anti-MUC1 monoclonal antibody in an ovarian cancer ascites model. Cancer Biol. Ther 2008, 7(1):76-80.
12. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
13. Farazi T.A., Hoell J.I., Morozov P., Tuschl T. MicroRNAs in human cancer. Adv. Exp. Med. Biol 2013, 774:1-20.
14. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet 2009, 10:704-714.
15. Farazi T.A., Spitzer J.I., Morozov P., Tuschl T. miRNAs in human cancer. J. Pathol 2011, 223:102-115.
16. Bueno M.J., Malumbres M. MicroRNAs and the cell cycle. Biochim. Biophys. Acta 2011, 12:592-601.
17. Sanchez-Diaz P.C., Hsiao T.H., Chang J.C., Yue D., Tan M.C., Chen H.I., et al. De-regulated MicroRNAs in pediatric cancer stem cells target pathways involved in cell proliferation, cell cycle and development. PLoS ONE 2013, 8. e61622.
18. Deng S., Calin G.A., Croce C.M., Coukos G., Zhang L. Mechanisms of microRNA deregulation in human cancer. Cell Cycle 2008, 7:2643-2646.
19. Allegra A., Alonci A., Campo S., Penna G., Petrungaro A., Gerace D., et al. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (Review). Int. J. Oncol 2012, 41:1897.
20. Sotillo E., Thomas-Tikhonenko A. Shielding the messenger (RNA): microRNA-based anticancer therapies. Pharmacol. Ther 2011, 131:18-32.
21. Xu B., Chen X., Mao Z., Chen M., Han X., Du G., et al. Perfluorooctane sulfonate disturbs Nanog expression through miR-490-3p in mouse embryonic stem cells. PLoS ONE 2013, 8(10). e74968.
22. Li S., Xu X., Xu X., Hu Z., Wu J., Zhu Y., et al. MicroRNA-490-5p inhibits proliferation of bladder cancer by targeting c-Fos. Biochem. Biophys. Res. Commun 2013, 441(4):976-981.
23. Kuroda S., Tam J., Roth J.A., Sokolov K., Ramesh R. EGFR-targeted plasmonic magnetic nanoparticles suppress lung tumor growth by abrogating G2/M cell-cycle arrest and inducing DNA damage. Int. J. Nanomedicine 2014, 9:3825-3839.
24. Hashiguchi Y., Tsuda H., Inoue T., Nishimura S., Suzuki T., Kawamura N. Alteration of cell cycle regulators correlates with survival in epithelial ovarian cancer patients. Hum. Pathol 2004, 35(2):165-175.
25. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J. Pathol 2003, 200(4):448-464.
26. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141(1):52-67.
27. Gialeli C., Theocharis A.D., Karamanos N.K. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 2011, 278(1):16-27.
28. Moroz A., Delella F.K., Lacorte L.M., Deffune E., Felisbino S.L. Fibronectin induces MMP2 expression in human prostate cancer cells. Biochem. Biophys. Res. Commun 2013, 430:1319-1321.
29. Park K.S., Kim S.J., Kim K.H., Kim J.C. Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer. J. Gastroenterol. Hepatol 2011, 26:391-397.
30. Lin Y.L., Ramanujum R., He S. Infection of Schistosomiasis japanicum is likely to enhance proliferation and migration of human breast cancer cells: mechanism of action of differential expression of MMP2 and MMP9. Asian Pac. J. Trop. Biomed 2011, 1:23-28.
31. Yoshizaki T., Sato H., Murono S., Pagano J.S., Furukawa M. Matrix metalloproteinase 9 is induced by the Epstein-Barr virus BZLF1 transactivator. Clin. Exp. Metastasis 1999, 17:431-436.
32. Ogden A., Rida P.C., Aneja R. Heading off with the herd: how cancer cells might maneuver supernumerary centrosomes for directional migration. Cancer Metastasis Rev 2013, 32(1-2):269-287.
33. Zhou L., Cai X., Han X., Xu N., Chang D.C. CDK1 switches mitotic arrest to apoptosis by phosphorylating Bcl-2/Bax family proteins during treatment with microtubule interfering agents. Cell Biol. Int 2014, 38(6):737-746.
34. Wei B., Song Y., Zhang Y., Hu M. microRNA-449a functions as a tumor-suppressor in gastric adenocarcinoma by targeting Bcl-2. Oncol. Lett 2013, 6(6):1713-1718.
35. Szegezdi E., Macdonald D.C., Ni Chonghaile T., Gupta S., Samali A. Bcl-2 family on guard at the ER. Am. J. Physiol. Cell Physiol 2009, 296:C941-C953.
36. Korbakis D., Scorilas A. Quantitative expression analysis of the apoptosis-related genes BCL2, BAX and BCL2L12 in gastric adenocarcinoma cells following treatment with the anticancer drugs cisplatin, etoposide and taxol. Tumour Biol 2012, 33:865-875.
37. Verde F., Dogterom M., Stelzer E., Karsenti E., Leibler S. Control of microtubule dynamics and length by cyclin A- and cyclin B-dependent kinases in Xenopus egg extracts. J. Cell Biol 1992, 118:1097-1108.